These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
160 related articles for article (PubMed ID: 16401307)
21. Effectiveness of the addition of ezetimibe to ongoing statin therapy in modifying lipid profiles and attaining low-density lipoprotein cholesterol goals in older and elderly patients: subanalyses of data from a randomized, double-blind, placebo-controlled trial. Pearson T; Denke M; McBride P; Battisti WP; Brady WE; Palmisano J Am J Geriatr Pharmacother; 2005 Dec; 3(4):218-28. PubMed ID: 16503317 [TBL] [Abstract][Full Text] [Related]
22. N-3 fatty acid supplementation decreases plasma homocysteine in diabetic dyslipidemia treated with statin-fibrate combination. Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B J Nutr Biochem; 2006 Jun; 17(6):379-84. PubMed ID: 16214329 [TBL] [Abstract][Full Text] [Related]
23. Cerivastatin improves insulin sensitivity and insulin secretion in early-state obese type 2 diabetes. Paniagua JA; López-Miranda J; Escribano A; Berral FJ; Marín C; Bravo D; Paz-Rojas E; Gómez P; Barcos M; Moreno JA; Pérez-Jiménez F Diabetes; 2002 Aug; 51(8):2596-603. PubMed ID: 12145176 [TBL] [Abstract][Full Text] [Related]
24. Effect of sulfhydryl and non-sulfhydryl angiotensin-converting enzyme inhibitors on endothelial function in essential hypertensive patients. Pasini AF; Garbin U; Nava MC; Stranieri C; Pellegrini M; Boccioletti V; Luchetta ML; Fabrizzi P; Lo Cascio V; Cominacini L Am J Hypertens; 2007 Apr; 20(4):443-50. PubMed ID: 17386354 [TBL] [Abstract][Full Text] [Related]
25. Switching fibrate to statin in type 2 diabetic patients: consequences on lipid profile. Meas T; Laloi-Michelin M; Virally M; Peynet J; Giraudeaux V; Kévorkian JP; Guillausseau PJ Eur J Intern Med; 2009 Mar; 20(2):197-200. PubMed ID: 19327612 [TBL] [Abstract][Full Text] [Related]
26. Effectiveness of rosuvastatin in low-density lipoprotein cholesterol lowering and National Cholesterol Education Program Adult Treatment Panel guideline III LDL-C goal attainment compared to other statins among diabetes mellitus patients: a retrospective study using an electronic medical records dataset in the United States. Fox KM; Gandhi SK; Ohsfeldt RL; Blasetto JW; Bays HE Curr Med Res Opin; 2007 Sep; 23(9):2125-33. PubMed ID: 17655813 [TBL] [Abstract][Full Text] [Related]
28. A randomized trial of the effect of statin and fibrate therapy on arterial function in CKD. Dogra G; Irish A; Chan D; Watts G Am J Kidney Dis; 2007 Jun; 49(6):776-85. PubMed ID: 17533020 [TBL] [Abstract][Full Text] [Related]
29. Improved vascular function upon pioglitazone treatment in type 2 diabetes is not associated with changes in mononuclear NF-kappaB binding activity. Rudofsky G; Reismann P; Grafe IA; Konrade I; Djuric Z; Tafel J; Buchbinder S; Zorn M; Humpert PM; Hamann A; Morcos M; Nawroth PP; Bierhaus A Horm Metab Res; 2007 Sep; 39(9):665-71. PubMed ID: 17846974 [TBL] [Abstract][Full Text] [Related]
30. Both cerivastatin and fenofibrate improve arterial vasoreactivity in patients with combined hyperlipidaemia. Sebestjen M; Zegura B; Keber I J Intern Med; 2002 Jan; 251(1):77-85. PubMed ID: 11851868 [TBL] [Abstract][Full Text] [Related]
31. [Effect of n-3 polyunsaturated fatty acids on plasma lipid, LDL lipoperoxidation, homocysteine and inflammation indicators in diabetic dyslipidemia treated with statin + fibrate combination]. Zeman M; Zák A; Vecka M; Tvrzická E; Písaríková A; Stanková B Cas Lek Cesk; 2005; 144(11):737-41. PubMed ID: 16335699 [TBL] [Abstract][Full Text] [Related]
32. Effect of ascorbic acid on microcirculation in patients with Type II diabetes: a randomized placebo-controlled cross-over study. Lu Q; Björkhem I; Wretlind B; Diczfalusy U; Henriksson P; Freyschuss A Clin Sci (Lond); 2005 Jun; 108(6):507-13. PubMed ID: 15675894 [TBL] [Abstract][Full Text] [Related]
33. Improvement of arterial stiffness by the antioxidant and anti-inflammatory effects of short-term statin therapy in patients with hypercholesterolemia. Matsuo T; Iwade K; Hirata N; Yamashita M; Ikegami H; Tanaka N; Aosaki M; Kasanuki H Heart Vessels; 2005 Feb; 20(1):8-12. PubMed ID: 15700196 [TBL] [Abstract][Full Text] [Related]
34. Serum interleukin-1 and interleukin-6 are correlated neither with oxidized low density lipoprotein, nor with low-grade inflammation in patients with type 2 diabetes. Morteza A; Nakhjavani M; Ghadiri-Anari A; Esteghamati A; Khalilzadeh O Eur Cytokine Netw; 2011 Jun; 22(2):107-12. PubMed ID: 21636350 [TBL] [Abstract][Full Text] [Related]
35. A 52-week, randomized, open-label, parallel-group comparison of the tolerability and effects of pitavastatin and atorvastatin on high-density lipoprotein cholesterol levels and glucose metabolism in Japanese patients with elevated levels of low-density lipoprotein cholesterol and glucose intolerance. Sasaki J; Ikeda Y; Kuribayashi T; Kajiwara K; Biro S; Yamamoto K; Ageta M; Kobori S; Saikawa T; Otonari T; Kono S Clin Ther; 2008 Jun; 30(6):1089-101. PubMed ID: 18640465 [TBL] [Abstract][Full Text] [Related]
36. Effect of cranberry extracts on lipid profiles in subjects with Type 2 diabetes. Lee IT; Chan YC; Lin CW; Lee WJ; Sheu WH Diabet Med; 2008 Dec; 25(12):1473-7. PubMed ID: 19046248 [TBL] [Abstract][Full Text] [Related]
37. The effect of statins on urinary albumin excretion and glomerular filtration rate: results from both a randomized clinical trial and an observational cohort study. Atthobari J; Brantsma AH; Gansevoort RT; Visser ST; Asselbergs FW; van Gilst WH; de Jong PE; de Jong-van den Berg LT; Nephrol Dial Transplant; 2006 Nov; 21(11):3106-14. PubMed ID: 16720593 [TBL] [Abstract][Full Text] [Related]
38. Hyperhomocysteinemia and elevated ox-LDL in Tunisian type 2 diabetic patients: role of genetic and dietary factors. Koubaa N; Nakbi A; Smaoui M; Abid N; Chaaba R; Abid M; Hammami M Clin Biochem; 2007 Sep; 40(13-14):1007-14. PubMed ID: 17618615 [TBL] [Abstract][Full Text] [Related]
39. Supplementation of hydrogen-rich water improves lipid and glucose metabolism in patients with type 2 diabetes or impaired glucose tolerance. Kajiyama S; Hasegawa G; Asano M; Hosoda H; Fukui M; Nakamura N; Kitawaki J; Imai S; Nakano K; Ohta M; Adachi T; Obayashi H; Yoshikawa T Nutr Res; 2008 Mar; 28(3):137-43. PubMed ID: 19083400 [TBL] [Abstract][Full Text] [Related]
40. Prolonged deterioration of endothelial dysfunction in response to postprandial lipaemia is attenuated by vitamin C in Type 2 diabetes. Anderson RA; Evans LM; Ellis GR; Khan N; Morris K; Jackson SK; Rees A; Lewis MJ; Frenneaux MP Diabet Med; 2006 Mar; 23(3):258-64. PubMed ID: 16492208 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]